La Jolla, Calif.-based Scripps Translational Science Institute tapped Fitbit as the first wearable for use in the All of Us Research Program, the company announced Nov. 7.
Digital Health
At least 1.1 million fewer Americans will enroll in health plans on the ACA exchanges next year due to a 90 percent cut in advertising funds, according to a blog post by Joshua Peck, former chief marketing officer of HealthCare.gov.
Vantari Genetics, Translational Software to provide genomics support to Banner Alzheimer's Institute
Vantari Genetics, a clinical diagnostics laboratory, and Translational Software, a genomics-driven clinical decision support provider, will provide services to Phoenix-based Banner Alzheimer's Institute's GeneMatch registry, the companies announced Oct. 23.
University of California San Francisco’s Center for Digital Health Innovation.UCSF’s Center for Digital Health Innovation is committed to pushing healthcare forward with new digital health technologies. The program helps innovators with the innovation, validation, integration and education of their digital…
WellCare of South Carolina, a subsidiary of WellCare Health Plans, launched a smartphone app to help Medicaid members in South Carolina manage their care, the health plan announced Oct. 4.
Advertisement
Former CMS officials and insurance executives launched an initiative Wednesday aimed at increasing public outreach ahead of the 2018 open enrollment season, CNBC reports.
The Ash Center for Democratic Governance and Innovation, a research center housed at the Cambridge, Mass.-based John F. Kennedy School of Management at Harvard University, unveiled a research effort focused on data sharing in healthcare Sept. 28.
Mark Schlissel, president of the Ann Arbor-based University of Michigan, unveiled a campuswide precision health research initiative at his annual leadership breakfast Oct. 3.
Three Indiana-based organizations — Indiana University in Bloomington, Regenstrief Institute in Indianapolis and LifeOmic in Indianapolis — entered into a precision medicine collaboration.
The Portland-based Oregon Health & Science University Knight Cancer Institute is partnering with Chicago-based Tempus, a technology company that analyzes molecular and clinical data to develop personalized cancer treatments, to improve care for breast, pancreatic and prostate cancer patients.